Amylyx Pharmaceuticals (AMLX) Change in Inventory (2022 - 2024)
Amylyx Pharmaceuticals (AMLX) posted quarterly Change in Inventory of $9.3 million for Q1 2024, down 30.44% year-over-year from $13.3 million in Q2 2023, and down 65.06% quarter-over-quarter from $26.5 million in Q4 2023.
Amylyx Pharmaceuticals (AMLX) Change in Inventory (2022 - 2024) Analysis & Trends
Amylyx Pharmaceuticals' Change in Inventory history runs 3 years deep, the most recent figure standing at $9.3 million for Q1 2024.
- In Q1 2024, Change in Inventory fell 30.44% year-over-year to $9.3 million; the TTM figure through Dec 2024 stood at $9.3 million (down 87.35% YoY), while the FY2024 annual figure was $9.3 million, down 87.35% from the prior year.
- Change in Inventory for Q1 2024 stood at $9.3 million, down from $26.5 million in the prior quarter.
- The five-year high for Change in Inventory was $26.5 million in Q4 2023, with the low at $9.2 million in Q4 2022.
- The 3-year median for Change in Inventory is $13.7 million (2023), against an average of $15.3 million.
- The sharpest annual moves came in 2023 and 2024: Change in Inventory soared 187.65% in 2023, then sank 30.44% in 2024.
- Amylyx Pharmaceuticals' Change in Inventory stood at $9.2 million in 2022, then jumped by 187.65% to $26.5 million in 2023, then tumbled by 65.06% to $9.3 million in 2024.
- Business Quant data shows AMLX's Change in Inventory at $9.3 million in Q1 2024, $26.5 million in Q4 2023, and $14.0 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Amylyx Pharmaceuticals | 4.35 Bn | 4.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 9.25 Mn |
| Mar 31, 2024 | 9.25 Mn |
| Dec 31, 2023 | 26.48 Mn |
| Dec 31, 2023 | 26.48 Mn |
| Sep 30, 2023 | 14.01 Mn |
| Sep 30, 2023 | 14.01 Mn |
| Jun 30, 2023 | 19.33 Mn |
| Jun 30, 2023 | 19.33 Mn |
| Mar 31, 2023 | 13.30 Mn |
| Mar 31, 2023 | 13.30 Mn |
| Dec 31, 2022 | 9.21 Mn |
| Dec 31, 2022 | 9.21 Mn |